Versartis - Improving Therapies, Improving Lives


About Versartis


Latest News


Ongoing Clinical Trial

Versartis, Inc. is a biopharmaceutical company developing long-acting therapeutic proteins for the treatment of endocrine disorders.

Versartis is developing new therapeutic proteins utilizing the novel half-life extension technology, XTEN. 

Partner with Us

The company is interested in exploring partnerships on our products to accelerate the development process and ensure successful commercialization. 



Versartis Trial in Children to Assess Long-Acting Growth Hormone (VERTICAL)

Contact Us

Versartis, Inc.
275 Shoreline Drive
Suite 450
Redwood City, CA 94065
(650) 963-8580